Cavernomas are vascular malformations with well-defined margins and a surrounding haemosiderin deposit, but no angiographically demonstrable lesion. Often these are asymptomatic lesions that require no therapy. Recurrent bleeding or other symptoms may be cured by surgical excision if they are easily accessible but frequently they are not. Two large series have established radiosurgery as the optimal therapy. Kondziolka et al. (5) reported 47 patients with bleeding cavernomas and noted a significant reduction in risk of bleeding from 32% per year to 9% per year. Kida et al. (6) analysed 51 cases presenting either as haemorrhage or intractable epilepsy. Haemorrhage was controlled in 86% and epilepsy was controlled in 64%. Permanent complications were 5%. The complication rate for radiosurgical treatment of cavernomas is unexpectedly high and this has been attributed to an amplification or radiosensitisation effect caused by the haemosiderin ring (7). For this reason doses should be less than for AVM of the same size and the haemosiderin ring should be excluded from the treatment plan.
REFERENCES